Horizon Pharma (NASDAQ:HZNP) will report earnings before markets open on Friday, May 10th. Horizon Pharma, Inc., is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation.
Here is your Cheat Sheet to Horizon Pharma Earnings:
Earnings Expectations: Analysts expect earnings of $-0.35 per share on revenues of $9.47 million.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0.45 to a loss $0.29. For the current year, the average estimate is a loss of $1.11, which is better than the estimate ninety days ago.
Here’s how Horizon Pharma has been performing on an annual basis:
|Revenue ($) in millions||0.00||0.00||2.38||6.93||19.63|
|Diluted EPS ($)||-21.16||-12.56||-2.26|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||3.53||2.52||3.84||6.52||6.75|
|Diluted EPS ($)||-3.898||-0.98||-0.68||-0.47||-0.3937|
Horizon Pharma has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)